메뉴 건너뛰기




Volumn 17, Issue 5, 2013, Pages

Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: A prospective study with the LiMAx test

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIMAX TEST; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SURVIVAL; APACHE; ARTIFICIAL VENTILATION; DIAGNOSTIC USE; LIVER DISEASES; MIDDLE AGED; PROCEDURES; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

EID: 84886736295     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13089     Document Type: Article
Times cited : (54)

References (42)
  • 1
    • 0034108825 scopus 로고    scopus 로고
    • The epidemiology of the systemic inflammatory response
    • 10.1007/s001340051121, 10786961
    • Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26:S64-S74. 10.1007/s001340051121, 10786961.
    • (2000) Intensive Care Med , vol.26
    • Brun-Buisson, C.1
  • 2
    • 9144220131 scopus 로고    scopus 로고
    • Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)
    • 10.1097/01.CCM.0000105118.66983.19, 14707554
    • Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004, 32:1-12. 10.1097/01.CCM.0000105118.66983.19, 14707554.
    • (2004) Crit Care Med , vol.32 , pp. 1-12
    • Bakker, J.1    Grover, R.2    McLuckie, A.3    Holzapfel, L.4    Andersson, J.5    Lodato, R.6    Watson, D.7    Grossman, S.8    Donaldson, J.9    Takala, J.10
  • 3
    • 0344497346 scopus 로고    scopus 로고
    • Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases
    • 10.1097/01.md.0000101573.54295.bd, 14663289
    • Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 2003, 82:392-406. 10.1097/01.md.0000101573.54295.bd, 14663289.
    • (2003) Medicine , vol.82 , pp. 392-406
    • Henrion, J.1    Schapira, M.2    Luwaert, R.3    Colin, L.4    Delannoy, A.5    Heller, F.R.6
  • 4
    • 32844461580 scopus 로고    scopus 로고
    • Jaundice in critical illness: promoting factors of a concealed reality
    • 10.1007/s00134-005-0023-3, 16450099
    • Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 2006, 32:267-274. 10.1007/s00134-005-0023-3, 16450099.
    • (2006) Intensive Care Med , vol.32 , pp. 267-274
    • Brienza, N.1    Dalfino, L.2    Cinnella, G.3    Diele, C.4    Bruno, F.5    Fiore, T.6
  • 5
    • 0036737893 scopus 로고    scopus 로고
    • Hepatic dysfunction increases length of stay and risk of death after injury
    • 10.1097/00005373-200209000-00020, 12352490
    • Harbrecht BG, Zenati MS, Doyle HR, McMichael J, Townsend RN, Clancy KD, Peitzman AB. Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 2002, 53:517-523. 10.1097/00005373-200209000-00020, 12352490.
    • (2002) J Trauma , vol.53 , pp. 517-523
    • Harbrecht, B.G.1    Zenati, M.S.2    Doyle, H.R.3    McMichael, J.4    Townsend, R.N.5    Clancy, K.D.6    Peitzman, A.B.7
  • 6
    • 34247158279 scopus 로고    scopus 로고
    • Incidence and prognosis of early hepatic dysfunction in critically ill patients - a prospective multicenter study
    • 10.1097/01.CCM.0000259462.97164.A0, 17334250
    • Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients - a prospective multicenter study. Crit Care Med 2007, 35:1099-1104. 10.1097/01.CCM.0000259462.97164.A0, 17334250.
    • (2007) Crit Care Med , vol.35 , pp. 1099-1104
    • Kramer, L.1    Jordan, B.2    Druml, W.3    Bauer, P.4    Metnitz, P.G.5
  • 8
    • 33847293718 scopus 로고    scopus 로고
    • Assessing liver function
    • 10.1097/MCC.0b013e328012b268, 17327744
    • Sakka SG. Assessing liver function. Curr Opin Crit Care 2007, 13:207-214. 10.1097/MCC.0b013e328012b268, 17327744.
    • (2007) Curr Opin Crit Care , vol.13 , pp. 207-214
    • Sakka, S.G.1
  • 9
    • 0034984292 scopus 로고    scopus 로고
    • Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival
    • 10.1097/00003246-200106000-00014, 11395594
    • Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163. 10.1097/00003246-200106000-00014, 11395594.
    • (2001) Crit Care Med , vol.29 , pp. 1159-1163
    • Kimura, S.1    Yoshioka, T.2    Shibuya, M.3    Sakano, T.4    Tanaka, R.5    Matsuyama, S.6
  • 10
    • 0036433328 scopus 로고    scopus 로고
    • Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients
    • 10.1378/chest.122.5.1715, 12426276
    • Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122:1715-1720. 10.1378/chest.122.5.1715, 12426276.
    • (2002) Chest , vol.122 , pp. 1715-1720
    • Sakka, S.G.1    Reinhart, K.2    Meier-Hellmann, A.3
  • 11
    • 9944243246 scopus 로고    scopus 로고
    • Monitoring of plasma disappearance rate of indocyanine green in a patient with necrotizing fasciitis and septic shock
    • 10.1055/s-2004-836080, 15558407
    • Kortgen A, Lindemann W, Bauer M. Monitoring of plasma disappearance rate of indocyanine green in a patient with necrotizing fasciitis and septic shock. Dtsch Med Wochenschr 2004, 129:2590-2593. 10.1055/s-2004-836080, 15558407.
    • (2004) Dtsch Med Wochenschr , vol.129 , pp. 2590-2593
    • Kortgen, A.1    Lindemann, W.2    Bauer, M.3
  • 12
    • 0002151081 scopus 로고    scopus 로고
    • Indocyanine green for the assessment of liver function in critically ill patients
    • Berlin: Springer, Vincent JL
    • Sakka S, Meier-Hellmann A. Indocyanine green for the assessment of liver function in critically ill patients. Yearbook of Intensive Care and Emergency Medicine 2001, 611-618. Berlin: Springer, Vincent JL.
    • (2001) Yearbook of Intensive Care and Emergency Medicine , pp. 611-618
    • Sakka, S.1    Meier-Hellmann, A.2
  • 13
    • 84864413405 scopus 로고    scopus 로고
    • Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation
    • 10.1016/j.transproceed.2012.05.023, 22841207
    • Escorsell A, Mas A, Fernandez J, Garcia-Valdecasas JC. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation. Transplant Proc 2012, 44:1539-1541. 10.1016/j.transproceed.2012.05.023, 22841207.
    • (2012) Transplant Proc , vol.44 , pp. 1539-1541
    • Escorsell, A.1    Mas, A.2    Fernandez, J.3    Garcia-Valdecasas, J.C.4
  • 15
    • 27944461324 scopus 로고    scopus 로고
    • Plasma disappearance of indocyanine green: a marker for excretory liver function?
    • 10.1007/s00134-005-2826-7, 16231068
    • Stehr A, Ploner F, Traeger K, Theisen M, Zuelke C, Radermacher P, Matejovic M. Plasma disappearance of indocyanine green: a marker for excretory liver function?. Intensive Care Med 2005, 31:1719-1722. 10.1007/s00134-005-2826-7, 16231068.
    • (2005) Intensive Care Med , vol.31 , pp. 1719-1722
    • Stehr, A.1    Ploner, F.2    Traeger, K.3    Theisen, M.4    Zuelke, C.5    Radermacher, P.6    Matejovic, M.7
  • 16
    • 75449118475 scopus 로고    scopus 로고
    • Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation
    • 10.1002/lt.21973, 20104485
    • Lock JF, Schwabauer E, Martus P, Videv N, Pratschke J, Malinowski M, Neuhaus P, Stockmann M. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl 2010, 16:172-180. 10.1002/lt.21973, 20104485.
    • (2010) Liver Transpl , vol.16 , pp. 172-180
    • Lock, J.F.1    Schwabauer, E.2    Martus, P.3    Videv, N.4    Pratschke, J.5    Malinowski, M.6    Neuhaus, P.7    Stockmann, M.8
  • 17
    • 77449091739 scopus 로고    scopus 로고
    • The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery
    • 10.1111/j.1477-2574.2009.00151.x, 2826673, 20495659
    • Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 2010, 12:139-146. 10.1111/j.1477-2574.2009.00151.x, 2826673, 20495659.
    • (2010) HPB (Oxford) , vol.12 , pp. 139-146
    • Stockmann, M.1    Lock, J.F.2    Malinowski, M.3    Niehues, S.M.4    Seehofer, D.5    Neuhaus, P.6
  • 18
    • 77956328248 scopus 로고    scopus 로고
    • How to define initial poor graft function after liver transplantation? A new functional definition by the LiMAx test
    • 10.1111/j.1432-2277.2010.01089.x, 20444241
    • Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, Neuhaus P. How to define initial poor graft function after liver transplantation? A new functional definition by the LiMAx test. Transpl Int 2010, 23:1023-1032. 10.1111/j.1432-2277.2010.01089.x, 20444241.
    • (2010) Transpl Int , vol.23 , pp. 1023-1032
    • Stockmann, M.1    Lock, J.F.2    Malinowski, M.3    Seehofer, D.4    Puhl, G.5    Pratschke, J.6    Neuhaus, P.7
  • 23
    • 34447646450 scopus 로고    scopus 로고
    • Defining acute renal failure: the RIFLE criteria
    • 10.1177/0885066607299510, 17712054
    • Venkataraman R, Kellum JA. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med 2007, 22:187-193. 10.1177/0885066607299510, 17712054.
    • (2007) J Intensive Care Med , vol.22 , pp. 187-193
    • Venkataraman, R.1    Kellum, J.A.2
  • 24
    • 0033845363 scopus 로고    scopus 로고
    • Thrombocytopenic disorders in critically ill patients
    • 10.1164/ajrccm.162.2.ncc3-00, 10934051
    • Drews RE, Weinberger SE. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000, 162:347-351. 10.1164/ajrccm.162.2.ncc3-00, 10934051.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 347-351
    • Drews, R.E.1    Weinberger, S.E.2
  • 25
    • 80052230985 scopus 로고    scopus 로고
    • Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan
    • 10.1111/j.1872-034X.2011.00860.x, 21884340
    • Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y, Ichida T, Tsubouchi H. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res 2011, 41:805-812. 10.1111/j.1872-034X.2011.00860.x, 21884340.
    • (2011) Hepatol Res , vol.41 , pp. 805-812
    • Mochida, S.1    Takikawa, Y.2    Nakayama, N.3    Oketani, M.4    Naiki, T.5    Yamagishi, Y.6    Ichida, T.7    Tsubouchi, H.8
  • 26
    • 17844365270 scopus 로고    scopus 로고
    • AASLD position paper: the management of acute liver failure
    • 10.1002/hep.20703, 15841455
    • Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41:1179-1197. 10.1002/hep.20703, 15841455.
    • (2005) Hepatology , vol.41 , pp. 1179-1197
    • Polson, J.1    Lee, W.M.2
  • 27
    • 84860532128 scopus 로고    scopus 로고
    • Systematic review: acute liver failure - one disease, more than 40 definitions
    • 10.1111/j.1365-2036.2012.05097.x, 22506515
    • Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure - one disease, more than 40 definitions. Aliment Pharmacol Ther 2012, 35:1245-1256. 10.1111/j.1365-2036.2012.05097.x, 22506515.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 1245-1256
    • Wlodzimirow, K.A.1    Eslami, S.2    Abu-Hanna, A.3    Nieuwoudt, M.4    Chamuleau, R.A.5
  • 29
    • 67949123384 scopus 로고    scopus 로고
    • Prognostic value of indocyanine green elimination assessed with LiMON in septic patients
    • 10.1016/j.jcrc.2008.11.012, 19327336
    • Inal MT, Memis D, Kargi M, Sut N. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care 2009, 24:329-334. 10.1016/j.jcrc.2008.11.012, 19327336.
    • (2009) J Crit Care , vol.24 , pp. 329-334
    • Inal, M.T.1    Memis, D.2    Kargi, M.3    Sut, N.4
  • 30
    • 79961182503 scopus 로고    scopus 로고
    • Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation
    • 10.1016/S1499-3872(11)60061-1, 21813383
    • Schneider L, Spiegel M, Latanowicz S, Weigand MA, Schmidt J, Werner J, Stremmel W, Eisenbach C. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatobiliary Pancreat Dis Int 2011, 10:362-368. 10.1016/S1499-3872(11)60061-1, 21813383.
    • (2011) Hepatobiliary Pancreat Dis Int , vol.10 , pp. 362-368
    • Schneider, L.1    Spiegel, M.2    Latanowicz, S.3    Weigand, M.A.4    Schmidt, J.5    Werner, J.6    Stremmel, W.7    Eisenbach, C.8
  • 32
    • 0032910299 scopus 로고    scopus 로고
    • Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine
    • 10.1177/026765919901400105, 10074644
    • Sharpe DA, Mitchel IM, Kay EA, McGoldrick JP, Munsch CM, Kay PH. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine. Perfusion 1999, 14:29-36. 10.1177/026765919901400105, 10074644.
    • (1999) Perfusion , vol.14 , pp. 29-36
    • Sharpe, D.A.1    Mitchel, I.M.2    Kay, E.A.3    McGoldrick, J.P.4    Munsch, C.M.5    Kay, P.H.6
  • 33
    • 0022654326 scopus 로고
    • Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity
    • 10.1002/jps.2600750417, 3723362
    • Heintz R, Svensson CK, Stoeckel K, Powers GJ, Lalka D. Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity. J Pharm Sci 1986, 75:398-402. 10.1002/jps.2600750417, 3723362.
    • (1986) J Pharm Sci , vol.75 , pp. 398-402
    • Heintz, R.1    Svensson, C.K.2    Stoeckel, K.3    Powers, G.J.4    Lalka, D.5
  • 34
    • 0016413391 scopus 로고
    • The handling of indocyanine green by the liver
    • Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975, 105:1-30.
    • (1975) Schweiz Med Wochenschr , vol.105 , pp. 1-30
    • Paumgartner, G.1
  • 35
    • 0001694046 scopus 로고
    • The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents
    • 10.1172/JCI104387, 290858, 13716909
    • Hunton DB, Bollman JL, Hoffman HN. The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents. J Clin Invest 1961, 40:1648-1655. 10.1172/JCI104387, 290858, 13716909.
    • (1961) J Clin Invest , vol.40 , pp. 1648-1655
    • Hunton, D.B.1    Bollman, J.L.2    Hoffman, H.N.3
  • 36
    • 0345701462 scopus 로고    scopus 로고
    • Repetitive short-term bile duct obstruction and relief causes reproducible and reversible bile acid regurgitation
    • 10.1016/S0022-4804(02)00082-3, 12697405
    • Baumgartner U, Scholmerich J, Feuerstein E, Baier P, Ihling C. Repetitive short-term bile duct obstruction and relief causes reproducible and reversible bile acid regurgitation. J Surg Res 2003, 110:222-227. 10.1016/S0022-4804(02)00082-3, 12697405.
    • (2003) J Surg Res , vol.110 , pp. 222-227
    • Baumgartner, U.1    Scholmerich, J.2    Feuerstein, E.3    Baier, P.4    Ihling, C.5
  • 37
    • 0024604994 scopus 로고
    • Biliary obstruction dissipates bioelectric sinusoidal-canalicular barrier without altering taurocholate uptake
    • Cotting J, Zysset T, Reichen J. Biliary obstruction dissipates bioelectric sinusoidal-canalicular barrier without altering taurocholate uptake. Am J Physiol 1989, 256:G312-G318.
    • (1989) Am J Physiol , vol.256
    • Cotting, J.1    Zysset, T.2    Reichen, J.3
  • 38
    • 77952484693 scopus 로고    scopus 로고
    • Hypoxic hepatitis - epidemiology, pathophysiology and clinical management
    • 10.1007/s00508-010-1357-6, 20361374
    • Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010, 122:129-139. 10.1007/s00508-010-1357-6, 20361374.
    • (2010) Wien Klin Wochenschr , vol.122 , pp. 129-139
    • Fuhrmann, V.1    Jager, B.2    Zubkova, A.3    Drolz, A.4
  • 40
    • 62949133380 scopus 로고    scopus 로고
    • A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis
    • 10.1007/s00134-008-1358-3, 19034423
    • Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M. A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med 2009, 35:717-721. 10.1007/s00134-008-1358-3, 19034423.
    • (2009) Intensive Care Med , vol.35 , pp. 717-721
    • Kruger, P.S.1    Freir, N.M.2    Venkatesh, B.3    Robertson, T.A.4    Roberts, M.S.5    Jones, M.6
  • 41
    • 34147115742 scopus 로고    scopus 로고
    • Drug-induced liver disease in 2006
    • 10.1097/MOG.0b013e3280b17dfb, 17414839
    • Arundel C, Lewis JH. Drug-induced liver disease in 2006. Curr Opin Gastroenterol 2007, 23:244-254. 10.1097/MOG.0b013e3280b17dfb, 17414839.
    • (2007) Curr Opin Gastroenterol , vol.23 , pp. 244-254
    • Arundel, C.1    Lewis, J.H.2
  • 42
    • 33646390145 scopus 로고    scopus 로고
    • Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients
    • 10.1007/s00134-006-0109-6, 16544120
    • Sakka SG, van Hout N. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med 2006, 32:766-769. 10.1007/s00134-006-0109-6, 16544120.
    • (2006) Intensive Care Med , vol.32 , pp. 766-769
    • Sakka, S.G.1    van Hout, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.